EQS-Ad-hoc: MediClin AG / Key word(s): Profit Warning/Forecast
MediClin AG:
19-Jan-2024 / 08:51 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Offenburg, January 19, 2024
MEDICLIN close to the sale of Herzzentrum Coswig; impairment losses lead to new, adjusted forecast for 2023
MEDICLIN Aktiengesellschaft (“MEDICLIN”) is on the final stage of selling the MEDICLIN Herzzentrum Coswig, Coswig. An agreement on all key points has already been reached with the potential buyer. The sales negotiations are in the final phase and a sale is assumed to be more likely than not. As part of the sales process, the MEDICLIN Herzzentrum Coswig will be reported as "assets held for sale" in the 2023 consolidated financial statements. There will be an impairment depending on the final purchase price, which, together with additionally identified impaired goodwill for two other facilities in the acute segment, will lead to a total negative impact on Group-EBIT of around EUR 30 million. Due to the negative impact on earnings, a Group-EBIT of EUR 10-15 million is now expected for 2023 instead of the published guidance of EUR 36-38 million.
19-Jan-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
Language:
English
Company:
MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone:
+49 (0)781 488-326
Fax:
+49 (0)781 488-184
E-mail:
alexandra.muehr@mediclin.de
Internet:
www.mediclin.de
ISIN:
DE0006595101
WKN:
659510
Listed:
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
Mediclin AG is a Germany-based operators of healthcare facilities. The Company operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).
MEDICLIN AG 
